PECAM1 and neoplasm: We also observed a significant decrease in the percentage of proliferating tumor cells (p < 0.01) and the number of blood vessels (p < 0.001) in KMT2B-knockdown tumors as determined by immunohistochemical staining for Ki67 and CD31 (Fig. 4J-L).